Back to search

Article

Pneumococcal Diseases Caused by Serotype Replacement in Colombia: A Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Infants and Its Herd Protection in Older Adults

2020-09-09

Abstract excerpt

<h4>Background: </h4> The recent and available evidence on the distribution of pneumococcal serotypes, which affects the effectiveness of pneumococcal conjugate vaccines (PCV), suggest that additional health economic studies will be important for better understanding of potential economic benefits of pneumococcal vaccination. <h4>Methods: </h4> A cohort simulation model was used for new births in Colombia between...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf83c29b-3963-58d6-855b-7360aed57c38
DOI
10.21203/rs.3.rs-72778/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pneumococcal Diseases Caused by Serotype Replacement in Colombia: A Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Infants and Its Herd Protection in Older AdultsDOI 10.21203/rs.3.rs-72778/v1
Cost-Effectiveness Analysis of Pneumococcal Vaccine in the Pediatric Population: A Systematic ReviewSemantic proximity
A model-based evaluation of the cost-effectiveness of paediatric and elderly vaccination against pneumococcal infection in EnglandSemantic proximity
Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infectionsSemantic proximity
Differences in Pneumococcal Serotype Replacement in Individuals with and without Underlying Medical ConditionsSemantic proximity
Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccinesSemantic proximity
Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022Semantic proximity
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceSemantic proximity
Nationwide Surveillance of Invasive Pneumococcal Disease in Spain: Impact of Conjugate Vaccines and the COVID-19 Pandemic (2009-2023)Semantic proximity
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing studySemantic proximity
Optimizing the timing of one or two doses of pneumococcal conjugate vaccines in older adults in the United States: a modeling studySemantic proximity
Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)Semantic proximity
Serotype distribution and risk factors associated with pneumococcal carriage among children with otitis media in Peninsular Malaysia (2023-2025): A cross-sectional study in the early post-vaccination eraSemantic proximity
Select a neighboring publication to make it the new centre.